摘要
残余肾功能(RRF)是影响透析患者存活率的重要因素。本文回顾血液透析以及腹膜透析患者保存RRF的重要性以及RRF的评估方法、影响因素与保护措施等。阐述降压药物尤其是血管紧张素转化酶抑制剂(ACEI)和血管紧张素II受体拮抗剂(ARB)对透析患者的独立于降压作用以外的RRF保护作用。
Residual renal function(RRF)is an important determinant of mortality and morbidity in patients undergoing dialysis.This paper reviews the importance of RRF,the measurement of RRF,factors that influence RRF in patients with haemodialysis and peritoneal dialysis,and measures to preserve RRF in dialysis patients.Evaluated therapeutic approaches,especially antihypertensive drugs such as angiotensin-converting enzyme inhibitor(ACEI)and angiotensin II receptor blockers(ARB),affect RRF in addition to blood presure...
出处
《世界临床药物》
CAS
2009年第2期76-81,共6页
World Clinical Drug
关键词
残余肾功能
降压药物
血液透析
腹膜透析
residual renal function
antihypertensive drugs
hemodialysis
peritoneal dialysis
